Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 675 of 715 entries
View as:

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00234637 Org: User:
Start: 11/30/03 End: 06/30/05 Due: 06/30/06

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Phase: N/A Priority: Normal
NCT ID: NCT01068860 Org: User:
Start: 02/28/10 End: 08/31/10 Due: 08/31/11

A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00856193 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

Phase: N/A Priority: Normal
NCT ID: NCT00701259 Org: User:
Start: 01/31/07 End: 08/31/07 Due: 08/31/08

Atrial Fibrillation Feasibility Certoparin Trial - AFFECT

Phase: N/A Priority: Normal
NCT ID: NCT00171769 Org: User:
Start: 04/30/05 End: - Due: -

Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

Phase: N/A Priority: Normal
NCT ID: NCT01335724 Org: User:
Start: 04/30/11 End: 07/31/11 Due: 07/31/12

Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00425997 Org: User:
Start: 12/31/06 End: 10/31/07 Due: 10/31/08

A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00134992 Org: User:
Start: 08/31/04 End: - Due: -

A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.

Phase: N/A Priority: Normal
NCT ID: NCT00171145 Org: User:
Start: 04/30/04 End: 12/31/04 Due: 12/31/05

Fluvastatin in Adults With Dislipidemia With History of Muscle Problems

Phase: N/A Priority: Normal
NCT ID: NCT00125125 Org: User:
Start: 05/31/05 End: 12/31/05 Due: 12/31/06

Safety of Lumiracoxib in Patients With Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00637949 Org: User:
Start: 12/31/00 End: 03/31/01 Due: 03/31/02

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00333489 Org: User:
Start: 03/31/04 End: 04/30/05 Due: 04/30/06

A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

Phase: N/A Priority: Normal
NCT ID: NCT00246584 Org: User:
Start: 10/31/04 End: - Due: -

Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00333567 Org: User:
Start: 08/31/06 End: - Due: -

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00415844 Org: User:
Start: 06/30/06 End: - Due: -

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)

Phase: N/A Priority: Normal
NCT ID: NCT01123941 Org: User:
Start: 05/31/10 End: 11/30/10 Due: 11/30/11

A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis

Phase: N/A Priority: Normal
NCT ID: NCT00248144 Org: User:
Start: 10/31/03 End: 07/31/07 Due: 07/31/08

Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Phase: N/A Priority: Normal
NCT ID: NCT00699166 Org: User:
Start: 04/30/04 End: 09/30/05 Due: 09/30/06

Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins

Phase: N/A Priority: Normal
NCT ID: NCT00377806 Org: User:
Start: 01/31/03 End: 09/30/06 Due: 09/30/07

Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil

Phase: N/A Priority: Normal
NCT ID: NCT00238966 Org: User:
Start: 11/30/02 End: 04/30/05 Due: 04/30/06

Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%

Phase: N/A Priority: Normal
NCT ID: NCT00138593 Org: User:
Start: 07/31/04 End: 07/31/06 Due: 07/31/07

The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT00277550 Org: User:
Start: - End: - Due: -

A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT00687804 Org: User:
Start: 05/31/08 End: 01/31/12 Due: 01/31/13

STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00006343 Org: User:
Start: 06/30/00 End: 03/31/07 Due: 03/31/08

An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00238485 Org: User:
Start: 01/31/05 End: 07/31/07 Due: 07/31/08